| |
| |
|
| Insider
Information: |
Carter Paul Rutherford |
| Relationship: |
Director |
| City: |
Uxbridge, Middlesex |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,305 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,228,017 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,305 |
|
|
| Total
Value |
$4,228,017 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP Commercial Ops |
2016-08-01 |
62,305 |
2014-02-10 |
0 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2022-06-16 |
0 |
2018-05-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP Commercial OpsOfficer |
• – – |
2014-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,133 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-02-10 |
4 |
OE |
$21.58 |
$360,907 |
D/D |
16,728 |
31,861 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-02-10 |
4 |
AS |
$79.10 |
$1,323,198 |
D/D |
(16,728) |
15,133 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-02-14 |
4 |
A |
$21.94 |
$15,559 |
D/D |
709 |
15,842 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-02-28 |
4 |
OE |
$23.60 |
$2,375,550 |
D/D |
99,000 |
114,842 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-02-28 |
4 |
S |
$83.55 |
$8,271,935 |
D/D |
(99,000) |
15,842 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-03-06 |
4 |
D |
$79.92 |
$901,498 |
D/D |
(11,280) |
28,562 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
39,842 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-03-10 |
4 |
OE |
$21.58 |
$360,907 |
D/D |
16,728 |
45,290 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-03-10 |
4 |
AS |
$79.32 |
$1,326,833 |
D/D |
(16,728) |
28,562 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-04-08 |
4 |
OE |
$21.58 |
$408,689 |
D/D |
16,728 |
45,290 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-04-08 |
4 |
AS |
$70.20 |
$1,179,782 |
D/D |
(16,728) |
28,562 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-05-08 |
4 |
AS |
$78.80 |
$1,318,143 |
D/D |
(16,728) |
28,562 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-05-08 |
4 |
OE |
$26.99 |
$451,489 |
D/D |
16,728 |
45,290 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
21,290 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-05-10 |
4 |
D |
$79.76 |
$227,874 |
D/D |
(2,857) |
18,433 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-06-09 |
4 |
OE |
$26.99 |
$451,489 |
D/D |
16,728 |
47,433 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-06-09 |
4 |
AS |
$79.10 |
$1,328,645 |
D/D |
(16,728) |
30,705 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-07-08 |
4 |
AS |
$86.45 |
$1,446,074 |
D/D |
(16,728) |
30,705 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-07-08 |
4 |
OE |
$26.99 |
$451,489 |
D/D |
16,728 |
47,433 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
33,205 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-08-01 |
4 |
D |
$91.50 |
$111,630 |
D/D |
(1,220) |
31,985 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-08-08 |
4 |
OE |
$26.99 |
$451,489 |
D/D |
16,728 |
48,713 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-08-08 |
4 |
AS |
$91.54 |
$1,531,881 |
D/D |
(16,728) |
31,985 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2014-08-15 |
4 |
A |
$21.94 |
$5,684 |
D/D |
259 |
32,244 |
0 |
- |
|
106 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
